Cargando…
Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
Human campylobacteriosis represents an infectious enteritis syndrome caused by Campylobacter species, mostly Campylobacter jejuni. Given that C. jejuni infections are rising worldwide and antibiotic treatment is usually not indicated, novel treatment options for campylobacteriosis are needed. Urolit...
Autores principales: | Mousavi, Soraya, Weschka, Dennis, Bereswill, Stefan, Heimesaat, Markus M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823290/ https://www.ncbi.nlm.nih.gov/pubmed/33374868 http://dx.doi.org/10.3390/pathogens10010007 |
Ejemplares similares
-
Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022) -
The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020) -
Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021) -
Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021) -
Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)